Olga Illarionova

Relative expansion of CD19‐negative very‐early normal B‐cell precursors in children with acute lymphoblastic leukaemia after CD19 targeting by blinatumomab and CAR‐T cell therapy: implications for flow cytometric detection of minimal residual disease

Ekaterina Mikhailova, Alexandra Semchenkova, Olga Illarionova et al. · British Journal of Haematology · 2021 · 42 citations · Full text

Medicine, Hematology, Oncology +17

Lineage Conversion in Pediatric B-Cell Precursor Acute Leukemia under Blinatumomab Therapy

Alexandra Semchenkova, Ekaterina Mikhailova, Alexander Komkov et al. · International Journal of Molecular Sciences · 2022 · 38 citations · Full text

Medicine, Hematology, Oncology +17

Immunophenotypic changes of leukemic blasts in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia who have been treated with blinatumomab

Ekaterina Mikhailova, Evgeny V. Gluhanyuk, Olga Illarionova et al. · Haematologica · 2020 · 21 citations · Full text

Medicine, Hematology, Oncology +14

Reliable Flow-Cytometric Approach for Minimal Residual Disease Monitoring in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia after CD19-Targeted Therapy

Ekaterina Mikhailova, Olga Illarionova, Alexander Komkov et al. · Cancers · 2022 · 17 citations · Full text

Medicine, Hematology, Oncology +17

The influence of a dosage regimen of dexamethasone on detection of normal B-cell precursors in the bone marrow of children with BCP-ALL at the end of induction therapy

Ekaterina Mikhailova, Tatiana Verzhbitskaya, Julia Roumiantseva et al. · Pediatric Hematology/Oncology and Immunopathology · 2020 · 13 citations · Full text

Medicine, Hematology, Pediatrics +17